<DOC>
	<DOCNO>NCT02595242</DOCNO>
	<brief_summary>The purpose study determine whether Mitoxantrone Hydrochloride Liposome Injection plus Cyclophosphamide , Vincristine Prednison ( CNOP ) safe effective treatment Diffuse Large B Cell Lymphoma .</brief_summary>
	<brief_title>Safety Efficacy Study CNOP Chemotherapy Diffuse Large B Cell Lymphoma</brief_title>
	<detailed_description>Mitoxantrone Hydrochloride Liposome Injection kind anthraquinone compound , antineoplastic effect view preclinical test . The investigator´s phaseⅠstudy show drug´s toxicity manageable tolerable 20 mg/m2 . The purpose study determine whether Mitoxantrone Hydrochloride Liposome Injection plus Cyclophosphamide , Vincristine Prednison ( CNOP ) safe effective treatment Diffuse Large B Cell Lymphoma.Patients physical state , symptom , change size tumor , laboratory finding obtain on-study help research team decide Mitoxantrone Hydrochloride Liposome Injection plus Cyclophosphamide , Vincristine Prednison ( CNOP ) safe effective treatment Diffuse Large B Cell Lymphoma .</detailed_description>
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Lymphoma , B-Cell</mesh_term>
	<mesh_term>Lymphoma , Large B-Cell , Diffuse</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<mesh_term>Prednisone</mesh_term>
	<mesh_term>Mitoxantrone</mesh_term>
	<mesh_term>Vincristine</mesh_term>
	<criteria>Written inform consent prior study specific screening procedure ; Favorable index curative effect Diffuse Large B Cell Lymphoma confirm histological analysis ; ≥ 18 ≤ 70 year age , male female ; Advanced Lymphoma standard treatment fail ; May benefit anthracyclinebased drug ; ECOG performance status 02 ; More 4 week last chemotherapy , 4 week last biotherapy , 4 week last clinical trial drug therapy ; Life expectancy 3 month ; Sexually active woman childbearing potential must use medically acceptable form contraception ; Adequate hepatic , renal , cardiac hematologic function : leukocyte≥3.5×10^9/L , neutrophils≥2.0×10^9/L , platelets≥100×10^9/L , hemoglobin≥90g/L , creatinine clearance rate≤1.5×ULN , serum bilirubin≤1.5×ULN , ALT≤2.5×ULN ( 5×for liver metastasis ) , AST≤2.5×ULN ( 5×for liver metastasis ) , alkaline phosphatase≤200 IU/L , Electrocardiogram appear essentially normal , ejection fraction Heart Doppler ultrasound appear normal . Pregnant lactating woman ; Patients Multiple sclerosis ; Suffering serious internal disease , include serious heart attack , cerebrovascular disease , uncontrolled diabetes , uncontrolled hypertension , uncontrolled infection , Active peptic ulcer ; Mitoxantrone use ; The cumulative doxorubicin epirubicin inclusion surpass 360 mg/m2 600 mg/m2 , respectively ; Heart disease cause Anthracyclinebased drug use ; Other antineoplastic drug need use study ; History Anthracyclinebased drug allergy liposome drug allergy ; Uncontrolled primary brain tumor brain metastasis ;</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>November 2015</verification_date>
</DOC>